SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Digital Turbine, Inc. engages in mobile growth platform solutions for advertisers, publishers, carriers, and device original equipment manufacturers. It operates through the following segments: On Device Solutions and App Growth Platform. The On Device Solutions segment consists of products and services that simplify the discovery and delivery of mobile apps and content media for device end users. The App Growth Platform segment provides Advertising Solutions and Ad Monetization Solutions. The company was founded on November 6, 1998 and is headquartered in Austin, TX.

Digital Turbine Inc

Digital Turbines volatile pullback and range-bound trading are driving discussion, with traders debating whether low-volume selling and options activity are weighing on shares or creating a buying opportunity ahead of earnings. Bullish investors point to improving growth and cash flow, while others remain concerned about dilution and the stocks weakness.

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

The FDAs acceptance of Intellias lonvo-z application for priority review has focused attention on its potential to bring a one-time gene-editing treatment for hereditary angioedema toward commercialization. Bulls see the regulatory milestone and Phase 3 results as validation, while skeptics point to financing and launch risks and question why the shares have reacted modestly.

T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA.

T-Mobile US Inc

T-Mobile is drawing attention after SpaceXs spectrum deal intensified fears that Starlink Mobile could eventually compete with established wireless carriers, contributing to a sharp telecom selloff. Traders disagree on whether the threat warrants repricing now or is being overblown given the time, spectrum and ground infrastructure needed to build a rival network.

The mission of the Worldcoin project is to build the world’s largest identity and financial network as a public utility, giving ownership to everyone. A key component of the Worldcoin project is the development of the foundational infrastructure that will be important for a world where AI plays an increasingly large role.  The Worldcoin system revolves around World ID, a privacy-preserving global identity network. World ID enables users to verify their humanness online while maintaining their privacy through zero-knowledge proofs.  Using World ID, individuals will be able to prove that they are a real, unique human to any platform that integrates with the protocol, including to web3 systems, social networking sites, and governmental programs. This will enable fair airdrops or token/NFT sales, provide protection against bots/sybil attacks on social media, and enable the fairer distribution of limited governmental resources. Furthermore, World ID can also enable global democratic processes and novel forms of governance (e.g., via quadratic voting), and it may eventually show a path to AI-funded UBI. The Worldcoin token (WLD), alongside World ID, will let users participate in governing the Worldcoin protocol.   To engage with the Worldcoin protocol, individuals must first download a first wallet app that supports the creation of a World ID. Users visit a physical imaging device called the Orb to get their World ID Orb-verified. Orbs are operated by a network of independent local businesses called Orb Operators. The Orb uses multispectral sensors to verify humanness and uniqueness to issue an Orb-verified World ID, with all images being promptly deleted on-device per default (absent explicit consent to Data Custody). All Orb-verified World IDs holders are entitled to claim recurring grants of free WLD tokens, subject to certain availability restrictions. The WLD token is designed as a utility token with governance properties.

Worldcoin

Worldcoins sharp rally is driving attention, with traders pointing to the Grayscale ETF filing and renewed interest in its proof-of-human identity use case amid growing AI-agent activity; some also cite Eightcos large WLD holdings as a source of institutional interest. Optimism about further gains and a potential short squeeze is tempered by skepticism over the tokens volatility and the fact that ETF approval remains uncertain.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is drawing attention amid a high-volume rally and anticipation of founder Patrick Soon-Shiongs scheduled fireside chat, where investors are looking for trial updates. Traders also connect the broader NIH cancer-vaccine push to the companys investigational vaccine work; hopes for a partnership or short squeeze remain speculative.

Chainlink is the industry-standard decentralized oracle network that solves the "oracle problem" by connecting smart contracts with real-world data. Blockchains cannot access external information on their own, so Chainlink acts as a secure bridge, enabling smart contracts to react to real-world events using verified, tamper-proof data. It is widely considered one of the first decentralized oracle networks and is the market leader in bringing off-chain data on-chain.  The platform operates through a decentralized network of nodes that fetch, validate, and deliver data to smart contracts. When a contract requests information like a stock price, a committee of independent nodes retrieves and aggregates the data to reach consensus, then delivers a single trustworthy answer. Chainlink offers a suite of services including Data Feeds for asset prices, CCIP for cross-chain token transfers and messaging, Automation for triggering smart contract functions, and Proof of Reserve for verifying asset collateralization.  Chainlink has established itself as critical infrastructure for both DeFi and institutional adoption, with partnerships including Swift, Euroclear, Mastercard, UBS, ANZ, Fidelity International, and J.P. Morgan. Its institutional products include the Chainlink Runtime Environment for tokenized asset workflows, Confidential Compute for privacy-preserving computation, and the Automated Compliance Engine for embedding regulatory rules into smart contracts.  The LINK token is the native asset used to pay node operators for services, fund subscription accounts, and incentivize network security through staking. Node operators stake LINK as collateral, which can be slashed if they provide inaccurate data. Chainlink was co-founded in 2017 by Sergey Nazarov and Steve Ellis, who co-authored the white paper with Ari Juels, and raised $32 million in its September 2017 ICO.

ChainLink

LINKs volatile rebound and repeated tests of resistance have fueled breakout talk, with bulls accumulating on dips while bears warn the move could fade. Traders also debate whether Chainlinks institutional and tokenization adoption will translate into lasting value for the LINK token.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinias planned early exit from its Rockville headquarters and procedural extensions in its generic-patent litigation have fueled speculation that a sale or further settlements may be approaching, though neither is confirmed. Traders welcomed the share-price rebound but debated whether it reflects company-specific developments or broader biotech-sector strength, with some expecting the gains to fade.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

CVS is drawing attention over weaker 2027 Medicare Advantage star ratings for Aetna, which traders say could reduce bonus payments and pressure future margins; the setback is being contrasted with Humanas improved ratings. Some traders are bearish on the business impact, while others view the selloff as an oversold reaction.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Discussion centers on Compounds institutional push, including its institutional market launch, leadership changes, and planned V4 development; bullish traders also cite COMPs capped supply and anticipate a breakout. Others remain skeptical, pointing to its past underperformance and uneven price action.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

Long-term Treasury yields near multi-decade highs, amid inflation concerns tied partly to oil and expectations of a restrictive Fed, are weighing on TLT. Traders are split between expecting more downside as yields stay elevated and betting on a rebound or short squeeze after auction-related relief in yields.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sensex Today Trades Lower; ICICI Bank & Maruti Suzuki Top Losers

Indian share markets are trading lower with Sensex trading 301 points lower, and Nifty is trading 100 points lower.

Auto sector posts strong April numbers with Maruti leading the charge, but FY27 challenges loom

India's auto sector saw robust year-on-year growth in April, defying sequential dips attributed to high March bases and supply issues. Maruti Suzuki stood out with month-on-month gains, driven by GST benefits and strong demand across segments. Tractor and two-wheeler sales also showed strength, though auto ancillaries face margin pressure from rising commodity costs.

Maruti Suzuki Share Price Live Updates: India's auto demand to hold steady for 2-3 quarters, but global risks loom over exports, margins

Discover the Maruti Suzuki Stock Liveblog, your ultimate resource for real-time updates and insightful analysis on a prominent stock. Keep track of Maruti Suzuki with the latest details, including: Last traded price 13570.0, Market capitalization: 426958.7, Volume: 220, Price-to-earnings ratio 29.09, Earnings per share 466.9. Our comprehensive coverage combines fundamental and technical indicators to provide you with a comprehensive view of Maruti Suzuki's performance. Stay informed about breaking news that can sway Maruti Suzuki's trajectory in the market. With our expert insights and stock recommendations, make well-informed financial decisions. Join us on this journey as we explore the exciting potential of Maruti Suzuki. The data points are updated as on 09:01:13 AM IST, 05 May 2026

Brief India: Vedanta Ltd: Change in Dividend Policy! and more

In this briefing: Vedanta Ltd: Change in Dividend Policy! Primer: Maharashtra Seamless (MHS IN) - May 2026 GRSE’s Best Year: Breaking Records Maruti Suzuki FY26: Strong Performance, Capacity Ramp and Exports Drive Growth Ahead Eternal Limited: Blinkit’s Dominance Driving the USD 1Bn EBITDA Vision 1. Vedanta Ltd: Change in Dividend Policy! Vedanta has replaced its fixed 30%-of-profit dividend floor with a discretionary, board-driven framework. FY26 total payout of Rs. 13,279 crore is the lowest since FY21. The contractual floor was the primary anchor of Vedanta's yield stock identity. With five separate boards now governing payout decisions post-demerger, the income predictability that warranted a premium valuation disappears. The policy change is structurally tied to Vedanta Resources's deleveraging roadmap: lower mandatory upstreaming from VEDL gives the parent more flexibility to prioritize debt services. 2. Primer: Maharashtra Seamless (MHS IN) - May 2026 Maharashtra Seamless holds a dominant position in the Indian seamless pipes market with a 55% market share, positioning it as a key beneficiary of domestic infrastructure and energy sector capital expenditure.

Brief India: Primer: Maharashtra Seamless (MHS IN) - May 2026 and more

In this briefing: Primer: Maharashtra Seamless (MHS IN) - May 2026 GRSE’s Best Year: Breaking Records Maruti Suzuki FY26: Strong Performance, Capacity Ramp and Exports Drive Growth Ahead Eternal Limited: Blinkit’s Dominance Driving the USD 1Bn EBITDA Vision India Opens the Vault: 100% FDI in Insurance Changes the Game 1. Primer: Maharashtra Seamless (MHS IN) - May 2026 Maharashtra Seamless holds a dominant position in the Indian seamless pipes market with a 55% market share, positioning it as a key beneficiary of domestic infrastructure and energy sector capital expenditure. The company maintains a strong financial profile, characterized by a debt-free balance sheet, healthy cash flow generation, and a substantial liquid investment portfolio, providing significant operational and financial flexibility. Growth is supported by favorable government policies such as 'Make in India' and anti-dumping duties on Chinese imports, which protect domestic manufacturers and are expected to bolster volumes in both its core seamless and Electric Resistance Welded (ERW) pipe segments.

Sensex, Nifty Poised For Subdued Start; Sammaan Capital, Coal India, RBL Bank, Waaree Energies, Indigo On Stock Watchlist

Equity

Indian equities may pause after RBI-driven gains, with mixed global cues. 

Weak Expiry Session: Nifty Ends Below 25,200 Despite Late Recovery Led By Banks, Metals

Analyst sees sideways consolidation in Nifty unless it breaks above 25,361.

Festive Fervour Drives Auto Stocks: Maruti Hits Record High, Hyundai Shows Rally Signs

Auto stocks gained in a subdued market as Maruti Suzuki and Hyundai reported record Navratri sales.

Maruti Suzuki Stock Rises As GST 2.0 Ignites Demand — SEBI Analyst Flags Bullish Technical Setup

The analyst said Maruti Suzuki’s strong September sales, new SUV launches, and rising exports are helping sustain momentum even as domestic utility sales soften.

Trading Radar For September 23: Vedanta, KEC International, Birla Corp, NTPC Green Stocks Are On Investors’ Watchlist

Euro Pratik Sales is set to list on the primary indices today.

Maruti Suzuki India Ltd. engages in the manufacture, purchase and sale of motor vehicles, components, and spare parts. It includes facilitation facilitation of pre-owned car sales, fleet management and car financing. The company was founded on February 24, 1981 and is headquartered in New Delhi, India.

Current Price	11,420.00
Prev Close	11,228.00
Open	11,291.00
Dividend Yield	1.14%
50-Day Moving Average	12,841.12
Beta	-0.04
Avg. Volume	410,393.67
PE Ratio	25.05

52-Week High	17,370.00
52-Week Low	11,158.00
Market Capitalization	3.53T
EPS (Annual)	466.90
Price to Book	3.35
Revenue Per Employee	25.93M

Feed

News

Sentiment

Earnings

Fundamentals

Info

MARUTI.NSE Fundamentals